Division of Cardiovascular Diseases, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan.
Division of Cardiology, Department of Internal Medicine, Mount Sinai St. Luke's Hospital, New York, New York.
J Am Coll Cardiol. 2016 Sep 6;68(10):1066-81. doi: 10.1016/j.jacc.2016.05.086.
Recent randomized controlled trials have suggested that patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease may benefit more from multivessel percutaneous coronary intervention (PCI) compared with culprit vessel-only primary PCI. The American College of Cardiology, American Heart Association, and Society for Cardiovascular Angiography and Interventions recently published an updated recommendation on this topic. The purpose of this State-of-the-Art Review is to accurately document existing published reports, describe their limitations, and establish a base for future studies.
最近的随机对照试验表明,与罪犯血管单纯经皮冠状动脉介入治疗(PCI)相比,ST 段抬高型心肌梗死和多支冠状动脉疾病患者可能从多支血管 PCI 中获益更多。美国心脏病学会、美国心脏协会和心血管血管造影和介入学会最近就这一主题发布了一项更新的建议。本现状综述的目的是准确记录现有的已发表报告,描述其局限性,并为未来的研究奠定基础。